Sunesis Pharmaceuticals

Focused on the RandD of oncology therapeutics for the treatment of solid and hematologic cancers.

Launch date

1998

Employees

San Francisco California (HQ)

Revenues, earnings & profits over time

EUR	2015
R&D budget	22.0m

Source: Dealroom estimates

Date	Investors	Amount	Round
-	Bay City Capital Abingworth Aisling Capital Ignite 500 Vivo Capital	N/A	-
Dec 1998	N/A	$8.0m	Series A
Dec 1999	Warburg Pincus	$25.2m	Series B
Jul 2000	Credit Suisse First Boston	$60.0m	Series C
Dec 2002	N/A	$6.0m	Series C
Sep 2004	N/A	$14.0m	Series C
Oct 2005	N/A	N/A	IPO
Apr 2009	New Enterprise Associates	$43.5m	Post IPO Equity
Feb 2021	Viracta Therapeutics	N/A	Merger
Total Funding		AUD175m

Tech stackLearn more about the technologies and tools that this company uses.

Financials